Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Women’s Health Drugs Market Size by Type: 2016 VS 2021 VS 2027
1.2.2 EVISTA
1.2.3 XGEVA
1.2.4 Prolia
1.2.5 Mirena
1.2.6 Zometa
1.2.7 Reclast/Aclasta
1.2.8 Minastrin 24 Fe
1.2.9 Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
1.3 Market by Application
1.3.1 Global Women’s Health Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hormonal Infertility
1.3.3 Postmenopausal Osteoporosis
1.3.4 Endometriosis
1.3.5 Contraceptives
1.3.6 Menopause
1.3.7 Polycystic Ovary Syndrome
1.3.8 Other Applications
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trend
2.1 Global Women’s Health Drugs Market Perspective (2016-2027)
2.2 Global Women’s Health Drugs Growth Trends by Regions
2.2.1 Women’s Health Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Women’s Health Drugs Historic Market Size by Regions (2016-2021)
2.2.3 Women’s Health Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Industry Trends and Growth Strategy
2.3.1 Women’s Health Drugs Industry Trends
2.3.2 Women’s Health Drugs Market Drivers
2.3.3 Women’s Health Drugs Market Challenges
2.3.4 Women’s Health Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Women’s Health Drugs Players by Market Size
3.1.1 Players Covered: Ranking by Women’s Health Drugs Revenue
3.1.2 Global Top Women’s Health Drugs Players by Revenue (2016-2021)
3.1.3 Global Women’s Health Drugs Revenue Market Share by Players (2016-2021)
3.1.4 Global Women’s Health Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Women’s Health Drugs Market Concentration Ratio
3.2.1 Global Women’s Health Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 5 and Top 10 Players by Women’s Health Drugs Revenue in 2020
3.3 Women’s Health Drugs Key Players Head office and Area Served
3.4 Key Players Women’s Health Drugs Product Solution and Service
3.5 Date of Enter into Women’s Health Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Global Women’s Health Drugs Breakdown Data by Type (2016-2027)
4.1 Global Women’s Health Drugs Historic Market Size by Type (2016-2021)
4.2 Global Women’s Health Drugs Forecasted Market Size by Type (2022-2027)

5 Global Women’s Health Drugs Breakdown Data by Application (2016-2027)
5.1 Global Women’s Health Drugs Historic Market Size by Application (2016-2021)
5.2 Women’s Health Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Women’s Health Drugs Market Size (2016-2027)
6.2 Key Women’s Health Drugs Players Market Share in North America (2020-2021)
6.3 North America Women’s Health Drugs Market Size by Country
6.3.1 North America Women’s Health Drugs Sales by Country (2016-2021)
6.3.2 North America Women’s Health Drugs Market Size Forecast by Country (2022-2027)
6.4 U.S. Market Size Analysis
6.4.1 U.S. Women’s Health Drugs Market Size (2016-2027)
6.4.2 U.S. Women’s Health Drugs Market Size by Type (2016-2027)
6.4.3 U.S. Women’s Health Drugs Market Size by Application (2016-2027)
6.5 Canada Market Size Analysis
6.5.1 Canada Women’s Health Drugs Market Size (2016-2027)
6.5.2 Canada Women’s Health Drugs Market Size by Type (2016-2027)
6.5.3 Canada Women’s Health Drugs Market Size by Application (2016-2027)
7 Europe
7.1 Europe Women’s Health Drugs Market Size (2016-2027)
7.2 Key Women’s Health Drugs Players Market Share in Europe (2020-2021)
7.3 Europe Women’s Health Drugs Market Size by Country
7.3.1 Europe Women’s Health Drugs Sales by Country (2016-2021)
7.3.2 Europe Women’s Health Drugs Market Size Forecast by Country (2022-2027)
7.4 Germany Market Size Analysis
7.4.1 Germany Women’s Health Drugs Market Size (2016-2027)
7.4.2 Germany Women’s Health Drugs Market Size by Type (2016-2027)
7.4.3 Germany Women’s Health Drugs Market Size by Application (2016-2027)
7.5 France Market Size Analysis
7.5.1 France Women’s Health Drugs Market Size (2016-2027)
7.5.2 France Women’s Health Drugs Market Size by Type (2016-2027)
7.5.3 France Women’s Health Drugs Market Size by Application (2016-2027)
7.6 U.K. Market Size Analysis
7.6.1 U.K. Women’s Health Drugs Market Size (2016-2027)
7.6.2 U.K. Women’s Health Drugs Market Size by Type (2016-2027)
7.6.3 U.K. Women’s Health Drugs Market Size by Application (2016-2027)
7.7 Italy Market Size Analysis
7.7.1 Italy Women’s Health Drugs Market Size (2016-2027)
7.7.2 Italy Women’s Health Drugs Market Size by Type (2016-2027)
7.7.3 Italy Women’s Health Drugs Market Size by Application (2016-2027)
7.8 Russia Market Size Analysis
7.8.1 Russia Women’s Health Drugs Market Size (2016-2027)
7.8.2 Russia Women’s Health Drugs Market Size by Type (2016-2027)
7.8.3 Russia Women’s Health Drugs Market Size by Application (2016-2027)
8 Asia-Pacific
8.1 Asia-Pacific Women’s Health Drugs Market Size (2016-2027)
8.2 Key Women’s Health Drugs Players Market Share in Asia-Pacific (2020-2021)
8.3 Asia-Pacific Women’s Health Drugs Market Size by Region
8.3.1 Asia-Pacific Women’s Health Drugs Sales by Region (2016-2021)
8.3.2 Asia-Pacific Women’s Health Drugs Market Size Forecast by Region (2022-2027)
8.4 China Market Size Analysis
8.4.1 China Women’s Health Drugs Market Size (2016-2027)
8.4.2 China Women’s Health Drugs Market Size by Type (2016-2027)
8.4.3 China Women’s Health Drugs Market Size by Application (2016-2027)
8.5 Japan Market Size Analysis
8.5.1 Japan Women’s Health Drugs Market Size (2016-2027)
8.5.2 Japan Women’s Health Drugs Market Size by Type (2016-2027)
8.5.3 Japan Women’s Health Drugs Market Size by Application (2016-2027)
8.6 South Korea Market Size Analysis
8.6.1 South Korea Women’s Health Drugs Market Size (2016-2027)
8.6.2 South Korea Women’s Health Drugs Market Size by Type (2016-2027)
8.6.3 South Korea Women’s Health Drugs Market Size by Application (2016-2027)
8.7 India Market Size Analysis
8.7.1 India Women’s Health Drugs Market Size (2016-2027)
8.7.2 India Women’s Health Drugs Market Size by Type (2016-2027)
8.7.3 India Women’s Health Drugs Market Size by Application (2016-2027)
8.8 Australia Market Size Analysis
8.8.1 Australia Women’s Health Drugs Market Size (2016-2027)
8.8.2 Australia Women’s Health Drugs Market Size by Type (2016-2027)
8.8.3 Australia Women’s Health Drugs Market Size by Application (2016-2027)
8.9 Taiwan Market Size Analysis
8.9.1 Taiwan Women’s Health Drugs Market Size (2016-2027)
8.9.2 Taiwan Women’s Health Drugs Market Size by Type (2016-2027)
8.9.3 Taiwan Women’s Health Drugs Market Size by Application (2016-2027)
8.10 Indonesia Market Size Analysis
8.10.1 Indonesia Women’s Health Drugs Market Size (2016-2027)
8.10.2 Indonesia Women’s Health Drugs Market Size by Type (2016-2027)
8.10.3 Indonesia Women’s Health Drugs Market Size by Application (2016-2027)
8.11 Thailand Market Size Analysis
8.11.1 Thailand Women’s Health Drugs Market Size (2016-2027)
8.11.2 Thailand Women’s Health Drugs Market Size by Type (2016-2027)
8.11.3 Thailand Women’s Health Drugs Market Size by Application (2016-2027)
8.12 Malaysia Market Size Analysis
8.12.1 Malaysia Women’s Health Drugs Market Size (2016-2027)
8.12.2 Malaysia Women’s Health Drugs Market Size by Type (2016-2027)
8.12.3 Malaysia Women’s Health Drugs Market Size by Application (2016-2027)
8.13 Philippines Market Size Analysis
8.13.1 Philippines Women’s Health Drugs Market Size (2016-2027)
8.13.2 Philippines Women’s Health Drugs Market Size by Type (2016-2027)
8.13.3 Philippines Women’s Health Drugs Market Size by Application (2016-2027)
8.14 Vietnam Market Size Analysis
8.14.1 Vietnam Women’s Health Drugs Market Size (2016-2027)
8.14.2 Vietnam Women’s Health Drugs Market Size by Type (2016-2027)
8.14.3 Vietnam Women’s Health Drugs Market Size by Application (2016-2027)
9 Latin America
9.1 Latin America Women’s Health Drugs Market Size (2016-2027)
9.2 Key Women’s Health Drugs Players Market Share in Latin America (2020-2021)
9.3 Latin America Women’s Health Drugs Market Size by Country
9.3.1 Latin America Women’s Health Drugs Sales by Country (2016-2021)
9.3.2 Latin America Women’s Health Drugs Market Size Forecast by Country (2022-2027)
9.4 Mexico Market Size Analysis
9.4.1 Mexico Women’s Health Drugs Market Size (2016-2027)
9.4.2 Mexico Women’s Health Drugs Market Size by Type (2016-2027)
9.4.3 Mexico Women’s Health Drugs Market Size by Application (2016-2027)
9.5 Brazil Market Size Analysis
9.5.1 Brazil Women’s Health Drugs Market Size (2016-2027)
9.5.2 Brazil Women’s Health Drugs Market Size by Type (2016-2027)
9.5.3 Brazil Women’s Health Drugs Market Size by Application (2016-2027)
9.6 Argentina Market Size Analysis
9.6.1 Argentina Women’s Health Drugs Market Size (2016-2027)
9.6.2 Argentina Women’s Health Drugs Market Size by Type (2016-2027)
9.6.3 Argentina Women’s Health Drugs Market Size by Application (2016-2027)
10 Middle East & Africa
10.1 Middle East & Africa Women’s Health Drugs Market Size (2016-2027)
10.2 Key Women’s Health Drugs Players Market Share in Middle East & Africa (2020-2021)
10.3 Middle East & Africa Women’s Health Drugs Market Size by Country
10.3.1 Middle East & Africa Women’s Health Drugs Sales by Country (2016-2021)
10.3.2 Middle East & Africa Women’s Health Drugs Market Size Forecast by Country (2022-2027)
10.4 Turkey Market Size Analysis
10.4.1 Turkey Women’s Health Drugs Market Size (2016-2027)
10.4.2 Turkey Women’s Health Drugs Market Size by Type (2016-2027)
10.4.3 Turkey Women’s Health Drugs Market Size by Application (2016-2027)
10.5 Saudi Arabia Market Size Analysis
10.5.1 Saudi Arabia Women’s Health Drugs Market Size (2016-2027)
10.5.2 Saudi Arabia Women’s Health Drugs Market Size by Type (2016-2027)
10.5.3 Saudi Arabia Women’s Health Drugs Market Size by Application (2016-2027)
10.6 UAE Market Size Analysis
10.6.1 UAE Women’s Health Drugs Market Size (2016-2027)
10.6.2 UAE Women’s Health Drugs Market Size by Type (2016-2027)
10.6.3 UAE Women’s Health Drugs Market Size by Application (2016-2027)

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview and Its Total Revenue
11.1.3 Bayer AG Women’s Health Drugs Introduction
11.1.4 Bayer AG Revenue in Women’s Health Drugs Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview and Its Total Revenue
11.2.3 Allergan Women’s Health Drugs Introduction
11.2.4 Allergan Revenue in Women’s Health Drugs Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Merck & Co
11.3.1 Merck & Co Company Details
11.3.2 Merck & Co Business Overview and Its Total Revenue
11.3.3 Merck & Co Women’s Health Drugs Introduction
11.3.4 Merck & Co Revenue in Women’s Health Drugs Business (2016-2021)
11.3.5 Merck & Co Recent Development
11.4 Pfizer Inc
11.4.1 Pfizer Inc Company Details
11.4.2 Pfizer Inc Business Overview and Its Total Revenue
11.4.3 Pfizer Inc Women’s Health Drugs Introduction
11.4.4 Pfizer Inc Revenue in Women’s Health Drugs Business (2016-2021)
11.4.5 Pfizer Inc Recent Development
11.5 Amgen
11.5.1 Amgen Company Details
11.5.2 Amgen Business Overview and Its Total Revenue
11.5.3 Amgen Women’s Health Drugs Introduction
11.5.4 Amgen Revenue in Women’s Health Drugs Business (2016-2021)
11.5.5 Amgen Recent Development
11.6 Agile Therapeutics Inc
11.6.1 Agile Therapeutics Inc Company Details
11.6.2 Agile Therapeutics Inc Business Overview and Its Total Revenue
11.6.3 Agile Therapeutics Inc Women’s Health Drugs Introduction
11.6.4 Agile Therapeutics Inc Revenue in Women’s Health Drugs Business (2016-2021)
11.6.5 Agile Therapeutics Inc Recent Development
11.7 Ferring Pharmaceuticals
11.7.1 Ferring Pharmaceuticals Company Details
11.7.2 Ferring Pharmaceuticals Business Overview and Its Total Revenue
11.7.3 Ferring Pharmaceuticals Women’s Health Drugs Introduction
11.7.4 Ferring Pharmaceuticals Revenue in Women’s Health Drugs Business (2016-2021)
11.7.5 Ferring Pharmaceuticals Recent Development
11.8 Mylan N.V.
11.8.1 Mylan N.V. Company Details
11.8.2 Mylan N.V. Business Overview and Its Total Revenue
11.8.3 Mylan N.V. Women’s Health Drugs Introduction
11.8.4 Mylan N.V. Revenue in Women’s Health Drugs Business (2016-2021)
11.8.5 Mylan N.V. Recent Development
11.9 Lupin (India)
11.9.1 Lupin (India) Company Details
11.9.2 Lupin (India) Business Overview and Its Total Revenue
11.9.3 Lupin (India) Women’s Health Drugs Introduction
11.9.4 Lupin (India) Revenue in Women’s Health Drugs Business (2016-2021)
11.9.5 Lupin (India) Recent Development
11.10 Eli Lilly And Company
11.10.1 Eli Lilly And Company Company Details
11.10.2 Eli Lilly And Company Business Overview and Its Total Revenue
11.10.3 Eli Lilly And Company Women’s Health Drugs Introduction
11.10.4 Eli Lilly And Company Revenue in Women’s Health Drugs Business (2016-2021)
11.10.5 Eli Lilly And Company Recent Development
11.11 Novartis AG
11.11.1 Novartis AG Company Details
11.11.2 Novartis AG Business Overview and Its Total Revenue
11.11.3 Novartis AG Women’s Health Drugs Introduction
11.11.4 Novartis AG Revenue in Women’s Health Drugs Business (2016-2021)
11.11.5 Novartis AG Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview and Its Total Revenue
11.12.3 Johnson & Johnson Women’s Health Drugs Introduction
11.12.4 Johnson & Johnson Revenue in Women’s Health Drugs Business (2016-2021)
11.12.5 Johnson & Johnson Recent Development

12 Analyst's Viewpoints/Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer

List of Figure

List of Tables
Table 1. Global Women’s Health Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2027
Table 2. Key Players of EVISTA
Table 3. Key Players of XGEVA
Table 4. Key Players of Prolia
Table 5. Key Players of Mirena
Table 6. Key Players of Zometa
Table 7. Key Players of Reclast/Aclasta
Table 8. Key Players of Minastrin 24 Fe
Table 9. Key Players of Others (Premarin, ACTONEL, ORTHO TRI-CY LO)
Table 10. Global Women’s Health Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Women’s Health Drugs Market Size by Region (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Women’s Health Drugs Market Size by Regions (2016-2021) (US$ Million)
Table 13. Global Women’s Health Drugs Market Share by Regions (2016-2021)
Table 14. Global Women’s Health Drugs Forecasted Market Size by Regions (2022-2027) (US$ Million)
Table 15. Global Women’s Health Drugs Market Share by Regions (2022-2027)
Table 16. Women’s Health Drugs Market Trends
Table 17. Women’s Health Drugs Market Drivers
Table 18. Women’s Health Drugs Market Challenges
Table 19. Women’s Health Drugs Market Restraints
Table 20. Ranking of Global Top Women’s Health Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 21. Global Women’s Health Drugs Revenue by Players (2016-2021) (US$ Million)
Table 22. Global Women’s Health Drugs Market Share by Players (2016-2021)
Table 23. Global Top Women’s Health Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women’s Health Drugs as of 2020)
Table 24. Global 5 Largest Players Market Share by Women’s Health Drugs Revenue (CR5 and HHI) (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Women’s Health Drugs Product Solution and Service
Table 27. Date of Enter into Women’s Health Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Women’s Health Drugs Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Women’s Health Drugs Revenue Market Share by Type (2016-2021)
Table 31. Global Women’s Health Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Women’s Health Drugs Revenue Market Share by Type (2022-2027)
Table 33. Global Women’s Health Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. Global Women’s Health Drugs Revenue Market Share by Application (2016-2021)
Table 35. Global Women’s Health Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Women’s Health Drugs Revenue Market Share by Application (2022-2027)
Table 37. Key Players Women’s Health Drugs Revenue in North America (2020-2021) (US$ Million)
Table 38. North America Women’s Health Drugs Market Size by Countries (2016-2021) (US$ Million)
Table 39. North America Women’s Health Drugs Market Size Share by Countries (2016-2021)
Table 40. North America Women’s Health Drugs Market Size by Countries (2022-2027) (US$ Million)
Table 41. North America Women’s Health Drugs Market Size Share by Countries (2022-2027)
Table 42. Women’s Health Drugs Market Size (US$ Million) in U.S., Breakdown by Type (2016-2021)
Table 43. Women’s Health Drugs Market Size (US$ Million) in U.S., Breakdown by Type (2022-2027)
Table 44. Women’s Health Drugs Market Size (US$ Million) in U.S., Breakdown by Application (2016-2021)
Table 45. Women’s Health Drugs Market Size (US$ Million) in U.S., Breakdown by Application (2022-2027)
Table 46. Women’s Health Drugs Market Size (US$ Million) in Canada, Breakdown by Type (2016-2021)
Table 47. Women’s Health Drugs Market Size (US$ Million) in Canada, Breakdown by Type (2022-2027)
Table 48. Women’s Health Drugs Market Size (US$ Million) in Canada, Breakdown by Application (2016-2021)
Table 49. Women’s Health Drugs Market Size (US$ Million) in Canada, Breakdown by Application (2022-2027)
Table 50. Key Players Women’s Health Drugs Revenue in Europe (2020-2021) (US$ Million)
Table 51. Europe Women’s Health Drugs Market Size by Countries (2016-2021) (US$ Million)
Table 52. Europe Women’s Health Drugs Market Size Share by Countries (2016-2021)
Table 53. Europe Women’s Health Drugs Market Size by Countries (2022-2027) (US$ Million)
Table 54. Europe Women’s Health Drugs Market Size Share by Countries (2022-2027)
Table 55. Women’s Health Drugs Market Size (US$ Million) in Germany, Breakdown by Type (2016-2021)
Table 56. Women’s Health Drugs Market Size (US$ Million) in Germany, Breakdown by Type (2022-2027)
Table 57. Women’s Health Drugs Market Size (US$ Million) in Germany, Breakdown by Application (2016-2021)
Table 58. Women’s Health Drugs Market Size (US$ Million) in Germany, Breakdown by Application (2022-2027)
Table 59. Women’s Health Drugs Market Size (US$ Million) in France, Breakdown by Type (2016-2021)
Table 60. Women’s Health Drugs Market Size (US$ Million) in France, Breakdown by Type (2022-2027)
Table 61. Women’s Health Drugs Market Size (US$ Million) in France, Breakdown by Application (2016-2021)
Table 62. Women’s Health Drugs Market Size (US$ Million) in France, Breakdown by Application (2022-2027)
Table 63. Women’s Health Drugs Market Size (US$ Million) in U.K., Breakdown by Type (2016-2021)
Table 64. Women’s Health Drugs Market Size (US$ Million) in U.K., Breakdown by Type (2022-2027)
Table 65. Women’s Health Drugs Market Size (US$ Million) in U.K., Breakdown by Application (2016-2021)
Table 66. Women’s Health Drugs Market Size (US$ Million) in U.K., Breakdown by Application (2022-2027)
Table 67. Women’s Health Drugs Market Size (US$ Million) in Italy, Breakdown by Type (2016-2021)
Table 68. Women’s Health Drugs Market Size (US$ Million) in Italy, Breakdown by Type (2022-2027)
Table 69. Women’s Health Drugs Market Size (US$ Million) in Italy, Breakdown by Application (2016-2021)
Table 70. Women’s Health Drugs Market Size (US$ Million) in Italy, Breakdown by Application (2022-2027)
Table 71. Women’s Health Drugs Market Size (US$ Million) in Russia, Breakdown by Type (2016-2021)
Table 72. Women’s Health Drugs Market Size (US$ Million) in Russia, Breakdown by Type (2022-2027)
Table 73. Women’s Health Drugs Market Size (US$ Million) in Russia, Breakdown by Application (2016-2021)
Table 74. Women’s Health Drugs Market Size (US$ Million) in Russia, Breakdown by Application (2022-2027)
Table 75. Key Players Women’s Health Drugs Revenue in Asia-Pacific (2020-2021) (US$ Million)
Table 76. Asia-Pacific Women’s Health Drugs Market Size by Regions (2016-2021) (US$ Million)
Table 77. Asia-Pacific Women’s Health Drugs Market Size by Regions (2022-2027) (US$ Million)
Table 78. Women’s Health Drugs Market Size (US$ Million) in China, Breakdown by Type (2016-2021)
Table 79. Women’s Health Drugs Market Size (US$ Million) in China, Breakdown by Type (2022-2027)
Table 80. Women’s Health Drugs Market Size (US$ Million) in China, Breakdown by Application (2016-2021)
Table 81. Women’s Health Drugs Market Size (US$ Million) in China, Breakdown by Application (2022-2027)
Table 82. Women’s Health Drugs Market Size (US$ Million) in Japan, Breakdown by Type (2016-2021)
Table 83. Women’s Health Drugs Market Size (US$ Million) in Japan, Breakdown by Type (2022-2027)
Table 84. Women’s Health Drugs Market Size (US$ Million) in Japan, Breakdown by Application (2016-2021)
Table 85. Women’s Health Drugs Market Size (US$ Million) in Japan, Breakdown by Application (2022-2027)
Table 86. Women’s Health Drugs Market Size (US$ Million) in South Korea, Breakdown by Type (2016-2021)
Table 87. Women’s Health Drugs Market Size (US$ Million) in South Korea, Breakdown by Type (2022-2027)
Table 88. Women’s Health Drugs Market Size (US$ Million) in South Korea, Breakdown by Application (2016-2021)
Table 89. Women’s Health Drugs Market Size (US$ Million) in South Korea, Breakdown by Application (2022-2027)
Table 90. Women’s Health Drugs Market Size (US$ Million) in India, Breakdown by Type (2016-2021)
Table 91. Women’s Health Drugs Market Size (US$ Million) in India, Breakdown by Type (2022-2027)
Table 92. Women’s Health Drugs Market Size (US$ Million) in India, Breakdown by Application (2016-2021)
Table 93. Women’s Health Drugs Market Size (US$ Million) in India, Breakdown by Application (2022-2027)
Table 94. Women’s Health Drugs Market Size (US$ Million) in Australia, Breakdown by Type (2016-2021)
Table 95. Women’s Health Drugs Market Size (US$ Million) in Australia, Breakdown by Type (2022-2027)
Table 96. Women’s Health Drugs Market Size (US$ Million) in Australia, Breakdown by Application (2016-2021)
Table 97. Women’s Health Drugs Market Size (US$ Million) in Australia, Breakdown by Application (2022-2027)
Table 98. Women’s Health Drugs Market Size (US$ Million) in Taiwan, Breakdown by Type (2016-2021)
Table 99. Women’s Health Drugs Market Size (US$ Million) in Taiwan, Breakdown by Type (2022-2027)
Table 100. Women’s Health Drugs Market Size (US$ Million) in Taiwan, Breakdown by Application (2016-2021)
Table 101. Women’s Health Drugs Market Size (US$ Million) in Taiwan, Breakdown by Application (2022-2027)
Table 102. Women’s Health Drugs Market Size (US$ Million) in Indonesia, Breakdown by Type (2016-2021)
Table 103. Women’s Health Drugs Market Size (US$ Million) in Indonesia, Breakdown by Type (2022-2027)
Table 104. Women’s Health Drugs Market Size (US$ Million) in Indonesia, Breakdown by Application (2016-2021)
Table 105. Women’s Health Drugs Market Size (US$ Million) in Indonesia, Breakdown by Application (2022-2027)
Table 106. Key Players Women’s Health Drugs Revenue in Latin America (2020-2021) (US$ Million)
Table 107. Latin America Women’s Health Drugs Market Size by Countries (2016-2021) (US$ Million)
Table 108. Latin America Women’s Health Drugs Market Size by Countries (2022-2027) (US$ Million)
Table 109. Women’s Health Drugs Market Size (US$ Million) in Mexico, Breakdown by Type (2016-2021)
Table 110. Women’s Health Drugs Market Size (US$ Million) in Mexico, Breakdown by Type (2022-2027)
Table 111. Women’s Health Drugs Market Size (US$ Million) in Mexico, Breakdown by Application (2016-2021)
Table 112. Women’s Health Drugs Market Size (US$ Million) in Mexico, Breakdown by Application (2022-2027)
Table 113. Women’s Health Drugs Market Size (US$ Million) in Brazil, Breakdown by Type (2016-2021)
Table 114. Women’s Health Drugs Market Size (US$ Million) in Brazil, Breakdown by Type (2022-2027)
Table 115. Women’s Health Drugs Market Size (US$ Million) in Brazil, Breakdown by Application (2016-2021)
Table 116. Women’s Health Drugs Market Size (US$ Million) in Brazil, Breakdown by Application (2022-2027)
Table 117. Women’s Health Drugs Market Size (US$ Million) in Argentina, Breakdown by Type (2016-2021)
Table 118. Women’s Health Drugs Market Size (US$ Million) in Argentina, Breakdown by Type (2022-2027)
Table 119. Women’s Health Drugs Market Size (US$ Million) in Argentina, Breakdown by Application (2016-2021)
Table 120. Women’s Health Drugs Market Size (US$ Million) in Argentina, Breakdown by Application (2022-2027)
Table 121. Key Players Women’s Health Drugs Revenue in Middle East & Africa (2020-2021) (US$ Million)
Table 122. Middle East & Africa Women’s Health Drugs Market Size by Countries (2016-2021) (US$ Million)
Table 123. Middle East & Africa Women’s Health Drugs Market Size by Countries (2022-2027) (US$ Million)
Table 124. Women’s Health Drugs Market Size (US$ Million) in Turkey, Breakdown by Type (2016-2021)
Table 125. Women’s Health Drugs Market Size (US$ Million) in Turkey, Breakdown by Type (2022-2027)
Table 126. Women’s Health Drugs Market Size (US$ Million) in Turkey, Breakdown by Application (2016-2021)
Table 127. Women’s Health Drugs Market Size (US$ Million) in Turkey, Breakdown by Application (2022-2027)
Table 128. Women’s Health Drugs Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2016-2021)
Table 129. Women’s Health Drugs Market Size (US$ Million) in Saudi Arabia, Breakdown by Type (2022-2027)
Table 130. Women’s Health Drugs Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2016-2021)
Table 131. Women’s Health Drugs Market Size (US$ Million) in Saudi Arabia, Breakdown by Application (2022-2027)
Table 132. Women’s Health Drugs Market Size (US$ Million) in UAE, Breakdown by Type (2016-2021)
Table 133. Women’s Health Drugs Market Size (US$ Million) in UAE, Breakdown by Type (2022-2027)
Table 134. Women’s Health Drugs Market Size (US$ Million) in UAE, Breakdown by Application (2016-2021)
Table 135. Women’s Health Drugs Market Size (US$ Million) in UAE, Breakdown by Application (2022-2027)
Table 136. Bayer AG Company Details
Table 137. Bayer AG Business Overview
Table 138. Bayer AG Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 139. Bayer AG Women’s Health Drugs Women’s Health Drugs Product
Table 140. Bayer AG Recent Development
Table 141. Allergan Company Details
Table 142. Allergan Business Overview
Table 143. Allergan Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 144. Allergan Women’s Health Drugs Product
Table 145. Allergan Recent Development
Table 146. Merck & Co Company Details
Table 147. Merck & Co Business Overview
Table 148. Merck & Co Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 149. Merck & Co Women’s Health Drugs Product
Table 150. Merck & Co Recent Development
Table 151. Pfizer Inc Company Details
Table 152. Pfizer Inc Business Overview
Table 153. Pfizer Inc Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 154. Pfizer Inc Women’s Health Drugs Product
Table 155. Pfizer Inc Recent Development
Table 156. Amgen Company Details
Table 157. Amgen Business Overview
Table 158. Amgen Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 159. Amgen Women’s Health Drugs Product
Table 160. Amgen Recent Development
Table 161. Agile Therapeutics Inc Company Details
Table 162. Agile Therapeutics Inc Business Overview
Table 163. Agile Therapeutics Inc Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 164. Agile Therapeutics Inc Women’s Health Drugs Product
Table 165. Agile Therapeutics Inc Recent Development
Table 166. Ferring Pharmaceuticals Company Details
Table 167. Ferring Pharmaceuticals Business Overview
Table 168. Ferring Pharmaceuticals Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 169. Ferring Pharmaceuticals Women’s Health Drugs Product
Table 170. Ferring Pharmaceuticals Recent Development
Table 171. Mylan N.V. Company Details
Table 172. Mylan N.V. Business Overview
Table 173. Mylan N.V. Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 174. Mylan N.V. Women’s Health Drugs Product
Table 175. Mylan N.V. Recent Development
Table 176. Lupin (India) Company Details
Table 177. Lupin (India) Business Overview
Table 178. Lupin (India) Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 179. Lupin (India) Women’s Health Drugs Product
Table 180. Lupin (India) Recent Development
Table 181. Eli Lilly And Company Company Details
Table 182. Eli Lilly And Company Business Overview
Table 183. Eli Lilly And Company Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 184. Eli Lilly And Company Women’s Health Drugs Product
Table 185. Eli Lilly And Company Recent Development
Table 186. Novartis AG Company Details
Table 187. Novartis AG Business Overview
Table 188. Novartis AG Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 189. Novartis AG Women’s Health Drugs Product
Table 190. Novartis AG Recent Development
Table 191. Johnson & Johnson Company Details
Table 192. Johnson & Johnson Business Overview
Table 193. Johnson & Johnson Revenue in Women’s Health Drugs Business (2016-2021) (US$ Million)
Table 194. Johnson & Johnson Women’s Health Drugs Product
Table 195. Johnson & Johnson Recent Development
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Women’s Health Drugs Market Share by Type: 2020 & 2027
Figure 2. EVISTA Features
Figure 3. XGEVA Features
Figure 4. Prolia Features
Figure 5. Mirena Features
Figure 6. Zometa Features
Figure 7. Reclast/Aclasta Features
Figure 8. Minastrin 24 Fe Features
Figure 9. Others (Premarin, ACTONEL, ORTHO TRI-CY LO) Features
Figure 10. Global Women’s Health Drugs Market Share by Application: 2020 & 2027
Figure 11. Hormonal Infertility Case Studies
Figure 12. Postmenopausal Osteoporosis Case Studies
Figure 13. Endometriosis Case Studies
Figure 14. Contraceptives Case Studies
Figure 15. Menopause Case Studies
Figure 16. Polycystic Ovary Syndrome Case Studies
Figure 17. Other Applications Case Studies
Figure 18. Women’s Health Drugs Report Years Considered
Figure 19. Global Women’s Health Drugs Market Share by Regions: 2016 VS 2021 VS 2027
Figure 20. Global Women’s Health Drugs Market Size YoY Growth 2016-2027 (US$ Million)
Figure 21. Global Women’s Health Drugs Market Share by Regions (2022-2027)
Figure 22. Global Women’s Health Drugs Market Share by Players in 2020
Figure 23. Global Top Women’s Health Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Women’s Health Drugs as of 2020)
Figure 24. The Top 10 and 5 Players Market Share by Women’s Health Drugs Revenue in 2020
Figure 25. North America Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 26. U.S. Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 27. Canada Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 28. Europe Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 29. Germany Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 30. France Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 31. U.K. Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 32. Italy Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 33. Russia Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 34. Asia-Pacific Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 35. China Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 36. Japan Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 37. South Korea Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 38. India Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 39. Australia Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 40. Taiwan Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 41. Indonesia Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 42. Thailand Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 43. Malaysia Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 44. Philippines Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 45. Vietnam Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 46. Latin America Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 47. Mexico Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 48. Brazil Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 49. Argentina Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 50. Middle East & Africa Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 51. Turkey Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 52. Saudi Arabia Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 53. UAE Women’s Health Drugs Market Size YoY Growth (2016-2027) (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed